CUPID · Consumer Defensive · Household & Personal Products
Composite scorecard: 66/100 — Quality 97 · Valuation 3 · Momentum 100
| Share price | ₹207.27 |
| Market cap | ₹28,539 Cr |
| P/E ratio | 268.7 |
| P/B ratio | 63.2 |
| ROE | 80.5% |
| ROCE | 30.9% |
| Book value | ₹3.36 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹358 Cr | ₹108 Cr | 33.0% |
| 2025 | ₹183 Cr | ₹41 Cr | 23.0% |
| 2024 | ₹172 Cr | ₹40 Cr | 30.0% |
| 2023 | ₹156 Cr | ₹32 Cr | 24.7% |
| 2022 | — | — | — |
Cupid Limited designs, manufactures, markets, and exports male and female condoms in India. The company offers water based lubricant jellies; in vitro diagnostic kits, including rapid diagnostic, viral transport medium, typhoid antibody, syphilis antibody, HIV 1 and 2 kit antibody, dengue IgG/IgM, malaria Pf-Pv and Pf-PAN antigen, hepatitis B (HbsAg) antigen, hepatitis C (HCV) antibody, pregnancy detection testing kit, LH ovulation testing kit, and dengue NS1 testing kit; and personal care products including deodorants, perfumes, toilet sanitizers, menstrual cups, petroleum jelly, hair and bod